News and CommentAids

Ethics of AZT Studies in Poorer Countries Attacked

See allHide authors and affiliations

Science  16 May 1997:
Vol. 276, Issue 5315, pp. 1022
DOI: 10.1126/science.276.5315.1022

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


At a congressional hearing on bioethics held 8 May, a consumer-advocacy organization branded as unethical drug trials in developing countries aimed at preventing the transmission of HIV from mothers to infants. The U.S. government-sponsored studies incorporate a control group of pregnant women who receive only a placebo. But researchers and their sponsors vigorously defended the trials, testifying that they may answer critical questions for HIV-infected women in poor countries.